Ayrton Capital LLC - 31 Dec 2025 SCHEDULE 13G Report for Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share (APUS)

Filing Manager
Ayrton Capital LLC
Reporting Manager
Ayrton Capital LLC
Security
Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share
Symbol
APUS
Shares outstanding
13,984,194 shares
Disclosed Ownership
1,397,021 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
11 Feb 2026, 09:51:35 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Ayrton Capital LLC 10% 1,397,021 1,397,021 0 /s/ Waqas Khatri Waqas Khatri / Managing Member
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B 10% 1,397,021 1,397,021 0 /s/ Waqas Khatri Waqas Khatri / Director
Waqas Khatri 10% 1,397,021 1,397,021 0 /s/ Waqas Khatri Waqas Khatri